Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential

Environmental Health Perspectives

Volumn 123, Issue 1, 2015, Pages 49-56

  Attene Ramos, Matias S ^a   Huang, Ruili ^a   Michael, Sam ^a   Witt, Kristine L ^b   Richard, Ann ^c   Tice, Raymond R ^b   Simeonov, Anton ^a   Austin, Christopher P ^a   Xia, Menghang ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; POLLUTANT;

CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; HEPG2 CELL LINE; HIGH THROUGHPUT SCREENING; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; POLLUTANT; TOXICITY; TOXICITY TESTING;

ADENOSINE TRIPHOSPHATE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; HEP G2 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; TOXICITY TESTS;

EID: 84920090996     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408642.     Document Type: Article

References (45)

1. Aldridge WN, Street BW. 1964. Oxidative phosphorylation. Biochemical effects and properties of trialkyltins. Biochem J 91(2):287-297.
2. Attene-Ramos MS, Huang R, Sakamuru S, Witt KL, Beeson GC, Shou L, et al. 2013a. Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screening. Chem Res Toxicol 26(9):1323-1332.
3. Attene-Ramos MS, Miller N, Huang R, Michael S, Itkin M, Kavlock RJ, et al. 2013b. The Tox21 robotic platform for the assessment of environmental chemicals—from vision to reality. Drug Discov Today 18(15-16):716-723.
4. Barnes SJ, Weitzman PDJ. 1986. Organization of citric-acid cycle enzymes into a multienzyme cluster. FEBS Lett 201(2):267-270.
5. Bereiter-Hahn J, Vöth M. 1994. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 27(3):198-219.
6. Betina V, Kuzela S. 1987. Uncoupling effect of fungal hydroxyanthraquinones on mitochondrial oxidative-phosphorylation. Chem Biol Interact 62(2):179-189.
7. Bragadin M, Marton D. 1997. A proposal for a new mechanism of interaction of trialkyltin (TAT) compounds with mitochondria. J Inorg Biochem 68(1):75-78.
8. Cartee L, Davis C, Lin PS, Grant S. 2000. Chronic exposure to bryostatin-1 increases the radio sensitivity of U937 leukaemia cells ectopically expressing Bcl-2 through a non-apoptotic mechanism. Int J Radiat Biol 76(10):1323-1333.
9. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. 1993. the use of ATP bioluminescence as a measure of cell-proliferation and cytotoxicity. J Immunol Methods 160(1):81-88.
10. Dykens JA, Davis RE, Moos WH. 1999. Introduction to mitochondrial function and genomics. Drug Dev Res 46(1):2-13.
11. Gamble JG, Lehninger AL. 1973. Transport of ornithine and citrulline across the mitochondrial membrane. J Biol Chem 248(2):610-618.
12. Huang R, Xia M, Cho MH, Sakamuru S, Shinn P, Houck KA, et al. 2011. Chemical genomics profiling of environmental chemical modulation of human nuclear receptors. Environ Health Perspect 119:1142-1148; doi:10.1289/ehp.1002952.
13. Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, et al. 2006. Quantitative high-throughput screening: a titration-based approach that effi-ciently identifies biological activities in large chemical libraries. Proc Natl Acad Sci USA 103(31):11473-11478.
14. Kavlock RJ, Austin CP, Tice RR. 2009. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal 29(4):485-487.
15. Kohonen T. 2006. Self-organizing neural projections. Neural Netw 19(6-7):723-733.
16. Kowaltowski AJ, Turin J, Indig GL, Vercesi AE. 1999. Mitochondrial effects of triarylmethane dyes. J Bioenerg Biomembr 31(6):581-590.
17. Lambeth JD, Seybert DW, Lancaster JR, Salerno JC, Kamin H. 1982. Steroidogenic electron-transport in adrenal-cortex mitochondria. Mol Cell Biochem 45(1):13-31.
18. Lemasters JJ, Qian T, He L, Kim JS, Elmore SP, Cascio WE, et al. 2002. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 4(5):769-781.
19. Lenaz G. 1998. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta 1366(1-2):53-67.
20. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. 2001. Mitochondrial dysfunction in cardiac disease: ischemia—reperfusion, aging, and heart failure. J Mol Cell Cardiol 33(6):1065-1089.
21. Lill R, Diekert K, Kaut A, Lange H, Pelzer W, Prohl C, et al. 1999. The essential role of mitochondria in the biogenesis of cellular iron-sulfur proteins. Biol Chem 380(10):1157-1166.
22. Liu KZ, Schultz CP, Johnston JB, Beck FW, Al-Katib AM, Mohammad RM, et al. 1999. Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line. Leukemia 13(8):1273-1280.
23. Liu T, Brown DA, O’Rourke B. 2010. Role of mitochon-drial dysfunction in cardiac glycoside toxicity. J Mol Cell Cardiol 49(5):728-736.
24. McBride HM, Neuspiel M, Wasiak S. 2006. Mitochondria: more than just a powerhouse. Curr Biol 16(14):R551-R560.
25. Mitchell P. 1961. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191:144-148.
26. Mordente A, Meucci E, Silvestrini A, Martorana GE, Giardina B. 2012. Anthracyclines and mitochondria. Adv Exp Med Biol 942:385-419.
27. Nadanaciva S, Will Y. 2011. Investigating mitochondrial dysfunction to increase drug safety in the pharma-ceutical industry. Curr Drug Targets 12(6):774-782.
28. Nakagawa Y, Moldeus P. 1998. Mechanism of p-hydroxybenzoate ester-induced mitochondrial dysfunction and cytotoxicity in isolated rat hepato-cytes. Biochem Pharmacol 55(11):1907-1914.
29. Naven RT, Swiss R, Klug-McLeod J, Will Y, Greene N. 2013. The development of structure-activity relation ships for mitochondrial dysfunction: uncoup ling of oxidative phosphorylation. Toxicol Sci 131(1):271-278.
30. Nishikimi A, Kira Y, Kasahara E, Sato EF, Kanno T, Utsumi K, et al. 2001. Tributyltin interacts with mitochondria and induces cytochrome c release. Biochem J 356(Pt 2):621-626.
31. NTP (National Toxicology Program). 2004. A National Toxicology Program for the 21st Century. Roadmap to Achieve the NTP Vision. Available: http://ntp.niehs.nih.gov/ntp/about_ntp/ntpvision/ ntproadmap_508.pdf [accessed 22 September 2014].
32. Pacher P, Hajnóczky G. 2001. Propagation of the apoptotic signal by mitochondrial waves. EMBO J 20(15):4107-4121.
33. Pagliarani A, Nesci S, Ventrella V. 2013. Toxicity of organotin compounds: shared and unshared biochemical targets and mechanisms in animal cells. Toxicol In Vitro 27(2):978-990.
34. Pieczenik SR, Neustadt J. 2007. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 83(1):84-92.
35. Sakamuru S, Li X, Attene-Ramos MS, Huang R, Lu J, Shou L, et al. 2012. Application of a homogenous membrane potential assay to assess mitochondrial function. Physiol Genomics 44(9):495-503.
36. Saxena AK. 1987. Organotin compounds: toxicology and biomedicinal applications. Appl Organomet Chem 1(1):39-56.
37. Schmidt CW. 2010. Mito-conundrum unraveling environ-mental effects on mitochondria. Environ Health Perspect 118:A292-A297; doi:10.1289/ehp.118-a292.
38. Shukla SJ, Huang R, Austin CP, Xia M. 2010. The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15(23-24):997-1007.
39. Sjostrand FS. 1953. Electron microscopy of mitochondria and cytoplasmic double membranes. Nature 171(4340):30-32.
40. Sone N, Hagihara B. 1964. Inhibitory action of tri alkyltin compounds on oxidative phosphorylation in mitochondria. J Biochem 56:151-156.
41. Spycher S, Smejtek P, Netzeva TI, Escher BI. 2008. Toward a class-independent quantitative structure— activity relationship model for uncou-plers of oxidative phosphorylation. Chem Res Toxicol 21(4):911-927.
42. Tice RR, Austin CP, Kavlock RJ, Bucher JR. 2013. Improving the human hazard characterization of chemicals: a Tox21 update. Environ Health Perspect 121:756-765; doi:10.1289/ehp.1205784.
43. Tirmenstein MA, Hu CX, Gales TL, Maleeff BE, Narayanan PK, Kurali E, et al. 2002. Effects of troglitazone on HepG2 viability and mitochondrial function. Toxicol Sci 69(1):131-138.
44. Wang IK, Lin-Shiau SY, Lin JK. 1999. Induction of apopto sis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35(10):1517-1525.
45. Wang S, Wang Z, Grant S. 2003. Bryostatin 1 and UCN-01 potentiate 1-β-d-arabinofuranosyl cytosineinduced apoptosis in human myeloid leukemia cells through disparate mechanisms. Mol Pharmacol 63(1):232-242.